4.4612

3.06% -0.1688

Bioage Labs Inc (BIOA)

Overview News Price History Discussions Forecast

Bioage Labs Inc stock is traded at $4.4612, with a volume of 47,361. It is down -3.06% in the last 24 hours and down -4.71% over the past month. Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. Its Products are Azelaprag (BGE-105), an apelin receptor APJ agonist that increases weight loss and improves body composition combined with incretin drugs. and BGE-100 is targeting metabolic diseases and neuroinflammation.

Previous Close:

$4.63

Open:

$4.68

24h Volume:

47,361

Relative Volume:

0.07

Market Cap:

$161.86M

Revenue:

Net Income/Loss:

P/E Ratio:

EPS:

Net Cash Flow:

1W Performance:

+3.18%

1M Performance:

-4.71%

6M Performance:

+0.00%

1Y Performance:

+0.00%

1-Day Range:

$4.34

$4.68

1-Week Range:

$4.05

$4.68

52-Week Range:

$3.85

$26.62

Bioage Labs Inc Stock (BIOA) Company Profile

Name

Bioage Labs Inc

Sector

Healthcare (1188)

Industry

Drug Manufacturers - Specialty & Generic (1)

Phone

510-806-1445

Address

1445A SOUTH 50TH STREET, RICHMOND

Employee

Twitter

Next Earnings Date

Latest SEC Filings

BIOA's Discussions on Twitter

Compare BIOA with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
BIOA Bioage Labs Inc	4.475	161.86M	0	0	0	0.00
ZTS Zoetis Inc	168.78	75.15B	9.26B	2.49B	2.30B	5.47
HLN Haleon Plc Adr	10.62	47.71B	14.35B	1.85B	0	0.4023
TAK Takeda Pharmaceutical Co Adr	14.97	47.70B	30.25B	1.37B	5.08B	0.4257
TEVA Teva Pharmaceutical Industries Ltd Adr	16.18	18.75B	16.54B	-1.64B	749.00M	-1.45
ITCI Intra Cellular Therapies Inc	131.30	13.96B	612.78M	-86.37M	-62.91M	-0.87

Bioage Labs Inc Stock (BIOA) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Feb-28-25	Initiated	William Blair	Mkt Perform
Dec-10-24	Downgrade	Morgan Stanley	Overweight → Underweight
Dec-09-24	Downgrade	Citigroup	Buy → Neutral
Dec-09-24	Downgrade	Jefferies	Buy → Hold
Oct-21-24	Initiated	Citigroup	Buy
Oct-21-24	Initiated	Jefferies	Buy
Oct-21-24	Initiated	Morgan Stanley	Overweight

View All

Bioage Labs Inc Stock (BIOA) Latest News

09:50 AM

BIOA Investors Have Opportunity to Lead BioAge Labs, Inc. Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire

09:50 AM

06:54 AM

BIOAGE LABS, INC. (NASDAQ: BIOA) DEADLINE ALERT: Bernstein - GlobeNewswire

06:54 AM

05:45 AM

BioAge Labs, Inc. Sued for Securities Law ViolationsInvestors Should Contact The Gross Law Firm for More InformationBIOA - PR Newswire

05:45 AM

Mar 02, 2025

BIOA DEADLINE ALERT: BioAge Labs (BIOA) Investors with - GlobeNewswire

Mar 02, 2025

BIOA DEADLINE ALERT: BioAge Labs (BIOA) Investors with Losses Encouraged to Contact Hagens Berman Before Mar. 10th Deadline in Securities Class Action - GlobeNewswire Inc.

Mar 02, 2025

Investors in BioAge Labs, Inc. Should Contact Levi & Korsinsky Before March 10, 2025 to Discuss Your RightsBIOA - Stockhouse Publishing

Mar 02, 2025

2025-03-02 | BioAge Labs, Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky for More InformationBIOA | NDAQ:BIOA | Press Release - Stockhouse Publishing

Mar 02, 2025

William Blair Initiates Coverage of BioAge Labs (MUN:Y7G) with Market Perform Recommendation - Nasdaq

Mar 01, 2025

Feb 28, 2025

William Blair Initiates Coverage of BioAge Labs (BIOA) with Market Perform Recommendation - Nasdaq

Feb 28, 2025

BioAge Labs, Inc. Deadline Approaching: Kessler Topaz Meltzer & Check, LLP Reminds BioAge Labs, Inc. Investors of Deadline in Securities Fraud Class Action Lawsuit - PR Newswire

Feb 28, 2025

2025-02-28 | BioAge Labs, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before March 10, 2025 to Discuss Your RightsBIOA | NDAQ:BIOA | Press Release - Stockhouse Publishing

Feb 28, 2025

BIOA Deadline: BIOA Investors with Losses in Excess of $100K Have Opportunity to Lead BioAge Labs, Inc. Securities Lawsuit - Morningstar

Feb 28, 2025

BioAge Labs (BIOA) Shares Plummet After Discontinuing Trial Just 2 Months After IPO– Hagens Berman - The Bakersfield Californian

Feb 28, 2025

2025-02-28 | Levi & Korsinsky Reminds BioAge Labs, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 10, 2025BIOA | NDAQ:BIOA | Press Release - Stockhouse Publishing

Feb 28, 2025

Deadline Alert: BioAge Labs, Inc. (BIOA) Investors Who Lost - GlobeNewswire

Feb 28, 2025

BIOA STOCK ALERT: A Class Action has been filed on behalf - GlobeNewswire

Feb 28, 2025

William Blair Initiates BioAge Labs at Market Perform -February 28, 2025 at 07:55 am EST - Marketscreener.com

Feb 28, 2025

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 10, 2025 in BioAge LawsuitBIOA - Morningstar

Feb 28, 2025

Feb 27, 2025

Levi & Korsinsky Notifies BioAge Labs, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineBIOA - ACCESS Newswire

Feb 27, 2025

Hold Rating for BioAge Labs, Inc.: Balancing Innovative Potential with Competitive and Developmental Challenges - TipRanks

Feb 27, 2025

Shareholders that lost money on BioAge Labs, Inc.(BIOA) - GlobeNewswire

Feb 27, 2025

Shareholders that lost money on BioAge Labs, Inc.(BIOA) Urged to Join Class Action – Contact Levi & Korsinsky to Learn More - TradingView

Feb 27, 2025

2025-02-27 | Shareholders that lost money on BioAge Labs, Inc.(BIOA) should contact Levi & Korsinsky about pending Class ActionBIOA | NDAQ:BIOA | Press Release - Stockhouse Publishing

Feb 27, 2025

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of BioAge Labs - PR Newswire

Feb 27, 2025

BIOA Lawsuit Alert! Class Action Lawsuit Against BioAge Labs, Inc. - TipRanks

Feb 27, 2025

Class Action Filed Against BioAge Labs, Inc. (BIOA) Seeking Recovery for InvestorsContact Levi & Korsinsky - Stockhouse Publishing

Feb 27, 2025

Investors in BioAge Labs, Inc. Should Contact The Gross Law Firm Before March 10, 2025 to Discuss Your RightsBIOA - PR Newswire

Feb 27, 2025

BioAge Labs, Inc. Class Action: The Gross Law Firm Reminds - GlobeNewswire

Feb 27, 2025

Feb 26, 2025

BIOA DEADLINE: ROSEN, TOP-RANKED INVESTOR COUNSEL, - GlobeNewswire

Feb 26, 2025

BIOA CLASS ACTION NOTICE: BioAge Labs Investors that - GlobeNewswire

Feb 26, 2025

Bronstein, Gewirtz & Grossman, LLC Is Investigating BioAge Labs, Inc. (BIOA) And Encourages Stockholders to Connect - ACCESS Newswire

Feb 26, 2025